Validation of parkinsonian disease-related metabolic brain patterns

Movement Disorders

Volumn 28, Issue 4, 2013, Pages 547-551

  Teune, Laura K ^a   Renken, Remco J ^a   Mudali, Deborah ^b   De Jong, Bauke M ^a   Dierckx, Rudi A ^a   Roerdink, Jos B T M ^b   Leenders, Klaus L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Differential diagnosis; Disease specific metabolic brain patterns; FDG PET imaging; Multivariate statistical analysis technique; Parkinson's disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CLINICAL ASSESSMENT; CLINICAL RESEARCH; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; NEUROIMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RATING SCALE; SCALED SUBPROFILE MODEL; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME;

AGED; BRAIN; BRAIN MAPPING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84876143207     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25361     Document Type: Article

References (26)

1. Juh R, Kim J, Moon D, Choe B, Suh T. Different metabolic patterns analysis of parkinsonism on the 18F-FDG PET. Eur J Radiol. 2004;51:223-233.
2. Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage. 2005;26:912-921.
3. Teune LK, Bartels AL, de Jong BM, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord. 2010;25:2395-2404.
4. Moeller JR, Strother SC. A regional covariance approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab. 1991;11:A121-A135.
5. Spetsieris PG, Ma Y, Dhawan V, Eidelberg D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage. 2009;45:1241-1252.
6. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab. 2007;27:597-605.
7. Eckert T, Tang C, Ma Y, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord. 2008;23:727-733.
8. Poston KL, Tang CC, Eckert T, et al. Network correlates of disease severity in multiple system atrophy. Neurology. 2012; 78:1237-1244.
9. Spetsieris PG, Eidelberg D. Scaled subprofile modeling of resting state imaging data in parkinson's disease: methodological issues. Neuroimage. 2011;54:2899-2914.
10. Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9:149-158.
11. Litvan I, Bhatia KP, Burn DJ, et al. Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord. 2003;18:467-486.
12. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670-676.
13. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (steele-richardson-olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1-9.
14. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends Neurosci. 2009;32: 548-557.
15. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974:716-723.
16. Spetsieris PG, Dhawan V, Eidelberg D. Three-fold cross-validation of parkinsonian brain patterns. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:2906-2909.
17. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab. 2007;27:597-605.
18. Moeller JR, Nakamura T, Mentis MJ, et al. Reproducibility of regional metabolic covariance patterns: Comparison of four populations. J Nucl Med. 1999;40:1264-1269.
19. Borghammer P, Cumming P, Aanerud J, Gjedde A. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease. Neuroimage. 2009;45: 249-257.
20. Ma Y, Tang C, Moeller JR, Eidelberg D. Abnormal regional brain function in parkinson's disease: Truth or fiction? Neuroimage. 2009;45:260-266.
21. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861-870.
22. Hughes A, Daniel S, Kilford L, Lees A. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
23. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage. 2007;34:714-723.
24. Mure H, Hirano S, Tang CC, et al. Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects. Neuroimage. 2011;54:1244-1253.
25. Poston KL, Eidelberg D. Network biomarkers for the diagnosis and treatment of movement disorders. Neurobiol Dis. 2009;35: 141-147.
26. Quinlan JR. C4.5: Programs for Machine Learning. Morgan Kaufmann Publishers; 1993.